RE: RNS15 Jan 2021 18:29
Amazing what a little attention to investor relations can do. The RNS contained very little that we didn't already know - even if news about 2 new approved trial sites was welcome. I credit the new investors who have been round the block long enough to know that, with companies like Rene, you have to keep drip-feeding information into the market. Rene has got such a good story to be telling and they should be telling it at every opportunity.